ArticleBMC ophthalmology2026
Lipid-rich vitreous hemorrhage associated with lipemia retinalis in a young patient with proliferative diabetic retinopathy.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo report a rare case of coexisting lipemia retinalis and proliferative diabetic retinopathy in a young patient, complicated by chylous vitreous hemorrhage. CASE PRESENTATION: A 22-year-old female with a 10-year history of type 2 diabetes mellitus and hyperlipidemia presented with progressive bilateral vision loss over two weeks. Visual acuity was counting fingers at 20 cm in the right eye and 20/63 in the left eye. Fundus examination revealed creamy-white retinal vessels in both eyes and yellow-white, lipid-rich material in the right vitreous cavity, consistent with lipemia retinalis and vitreous hemorrhage. Laboratory testing demonstrated severe hypertriglyceridemia. After systemic lipid-lowering therapy, the appearance of the retinal vessels returned to normal, but visual impairment persisted. The patient subsequently underwent pars plana vitrectomy in the right eye and received bilateral intravitreal anti-vascular endothelial growth factor injections. At the five-month follow-up, visual acuity improved to 20/20 in the right eye and 20/25 in the left eye.
conclusionsLipemia retinalis reflects severe disturbances in lipid metabolism. Early metabolic control and individualized ophthalmic management are essential to optimize visual outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.